Skip to content
Menu

Barclays Maintains Overweight on Visteon, Lowers Price Target to $105

Benzinga Newsdesk 3 weeks ago

Analyst RatingsNewsPrice Target

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Barclays analyst Dan Levy maintains Visteon (NASDAQ:VC) with a Overweight and lowers the price target from $125 to $105.

Barclays analyst Dan Levy maintains Visteon (NASDAQ:VC) with a Overweight and lowers the price target from $125 to $105.

Read at benzinga.com

← All stock news